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Summary  
Staphylococcal enterotoxin B (SEB) is a bacterial superantigen (SAg) that predominantly inter- 
acts with VI38 + T cells. In vivo treatment of mice with SEB leads to an initial increase in the 
percentage of  V[~8 + T cells, followed by a decrease in the numbers of these cells, eventually 
reaching lower levels than those found before treatment with the SAg. This decrease is due to 
apoptosis of the SEB-responding cells. In the present study, we use the distinct light scattering 
characteristics ofapoptotic ells to characterize T cells that are being deleted in response to SEB 
in vivo. We show that dying, SEB-reactive T cells express high levels of  Fas and Fas ligand 
(Fas-L), which are implicated in apoptotic ell death. In addition, the B cell marker B220 is up- 
regulated on apoptotic ells. Moreover, we show that the generation of cells with an apoptotic 
phenotype is severely impaired in response to SEB in functional Fas-L-deficient mutant gld 
mice, confirming the role of the Fas pathway in SAg-mediated peripheral deletion in vivo. 
A fter in vivo challenge with conventional antigen or with superantigen (SAg) l, peripheral T cells undergo 
clonal expansion followed by apoptosis (1-6). The expres- 
sion of cell surface markers has been extensively studied in 
resting and activated T cells, and a substantial body of 
knowledge exists concerning the conditions under which 
T cells can undergo apoptosis. By contrast, little is known 
about the surface phenotype ofapoptotic ells and their ex- 
pression of molecules that may be implicated in their death. 
One such molecule is Fas/APO-1 (CD95), an integral 
membrane protein of  the TNFR family (7). Fas is ex- 
pressed on a variety of  cell lines and on in vitro-activated T 
cells (8). Cross-linking Fas with specific antibodies results 
in apoptosis (9). The ligand for Fas (Fas-L) is a member of 
the TNF  family, and is expressed on certain cell lines, in 
vitro-activated T cells, and freshly isolated NK cells (7, 10). 
Fas-L can deliver a death signal by triggering Fas (11, 12). 
In this study, we take advantage of the distinct light scatter- 
ing characteristics of dying cells on a flow cytometer (re- 
viewed in reference 13) to characterize SAg-specific T cells 
undergoing apoptosis. We show that apoptotic CD4 + or 
CD8 + cells retain expression of their TCR (albeit at lower 
levels) and simultaneously coexpress the B cell-specific 
epitope of CD45 (13220) together with high levels of Fas 
and Fas-L. Moreover, in gld mice that lack a functional 
Fas-L (14, 15), SAg-specific T cells with an apoptotic phe- 
tAbbreviations used in this paper: Fas-L, ligand for Fas; FSC, forward scatter- 
ing; SAg, superantigen; SEB, staphylococcal enterotoxin B; wt, wild type. 
notype are dramatically reduced despite a normal prolifera- 
tive response to SAg in vivo. 
Materials and Methods 
Animals and Treatments. 8-10-wk old BALB/c mice were 
obtained from Harlan Olac (Bicester, UK). C57BL/6 and con- 
genic B6SmnC3H-gld mice were purchased from The Jackson 
Laboratory (Bar Harbor, ME). The TCR V[38.2 transgenic 
mouse line (C57BL6.Tg93/lbm spf) (16) was kindly provided by 
Dr. H. Bluethmann (Hoffman-La R.oche AG, Basel, Switzer- 
land). These were backcrossed onto the BALB/c background. 
Staphylococcal enterotoxin B (SEB) (10 p~g) from Toxin Tech- 
nology (Sarasota, FL) was injected into each of the hind footpads. 
Antibodies. The following directly labeled primary Abs were 
used: anti-CD4-PE (Becton Dickinson and Co., Palo Alto, CA), 
anti-CD8-PE (Boehringer Mannheim, Mannheim, Germany); 
anti-V[38 (F23.1) (17), anti-V13 6 (44.22.1) (18), anti-CD3 (17A2) 
and (Fab')2 anti-mouse Ig, were directly coupled to FITC in our 
laboratory. Anti-B220 tricolor (RA3-6B2) was purchased from 
Caltag Laboratories (South San Francisco, CA). Affinity-purified 
polyclonal rabbit anti-Fas-L (PE62) (19) and rabbit anti-Fas 
(AL59, made against he NH2-terminal 12 residues of mouse Fas, 
Muller, C., and J. Tschopp, unpublished ata) antibodies were 
revealed by FITC-coupled onkey anti-rabbit Ig (Dianova, Ham- 
burg, Germany). Anti-FctL mAb (24G2) was purchased from 
Pharmingen (San Diego, CA). 
Flow Cytometric Analysis and Cell Sorting. Draining LN ceils were 
stained with the relevant antibodies and either sorted using a 
FACStar | Plus or analyzed on a FACScan | (Becton Dickinson 
and Co., Mountain View, CA). Sorted cells were incubated at 
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37~ for 1 h (to allow apoptosis to occur [2, 3]) before further 
manipulation. 
Simultaneous staining for BrdU and DNA content was per- 
formed as described (20). Briefly, cells were fixed in 70% ethanol 
for at least 30 rain and the DNA was partially denatured in 3 N 
HCI, then neutralized with 0.1 M NazB407. The cells were sub- 
sequently resuspended in 100 Ixl PBS containing 2.5% FCS, and 
added to 200 ILl PBS/FCS containing 3 ~g/ml propidium iodide, 
50 I.Lg/ml RNAse A (Sigma Chemical Co., St. Louis, MO), 50 
mM Tris base, 50 mM NaC1, and 5 mM EDTA, pH 7.5. Cells 
were then incubated 5 rain at 37~ and analyzed on a FACScan | 
equipped with a doublet discrimination module. 
Results 
SAg-specific T Cells Undergoing Apoptosis In Vivo Are For- 
ward Scattering (FSC) l~ Dying cells diminish in size before 
disintegrating and being cleared by phagocytes (21). In-  
deed, when undergoing apoptosis, thymocytes, trans- 
formed cells, and cultured splenocytes exhibit low FSC on 
a flow cytometer (13, 22-25), indicating decreased cell size. 
We have recently shown that in mice that were injected 
with SEB, massive apoptosis of  responding VJ38 + T cells (as 
assessed by subdiploid DNA content) is evident 7 d after 
administration of the SAg, coinciding with and accounting 
for the characteristic decrease in the percentage of  these T 
cells (26). Fig. 1 A shows that there is an increase in the 
proport ion o fFSC l~ cells in the LN of  BALB/c  mice that 
were injected with SEB 7 d earlier. To  confirm that the 
FSC l~ gate actually contains apoptotic cells, we analyzed 
the DNA content ofVI38 + T cells from SEB-treated mice. 
Fig. 1 B shows that the FSC l~ but not the FSC hig~, VJ38 + 
T cell populat ion contains a substantial proport ion of  sub- 
diploid, apoptotic ells. To  investigate whether the conver-  
sion to an FSC l~ phenotype is specific to SEB-reactive T 
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Figure 1. FSC ]~ population is enriched in SEB-reactive, apoptotic T cells. Mice were injected or no  with 10 ~g SEB in each of the hind footpads. 
LN cells were isolated 7 d later, stained, and analyzed by flow cytometry asdescribed in Materials and Methods. (A) Contour plot showing two distinct 
populations (FSC high or R1, and FSC l~ or tk2) based on light scattering parameters. The percentages shown indicate the number of cells in P,.2 as a per- 
centage of the number of cells in R1 + R.2. (B) DNA content of sorted, FSC l~ or FSC high CD4 + VIB8 + cells from SEB-injected mice. (C) Vl38 or VI36 
expression i FSC-gated, CD4 + T cells. These and all subsequent data are representative of at least two independent experiments. 
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Figure 2. Decreased accumulation of FSC t~ V[38 + T cells in SEB- 
treated gld mice. Forward and side scatter profiles of CD4 + V[38 + cells 
from control or SEB-injected wild type C57BL/6 (BL/6) or congenic 
B6SmnC3H-gld (gld) mice were analyzed by flow cytometry, and the 
percentage ofFSC j~ cells among total CD4 + V~8 + T cells was calculated 
as described in the legend to Fig. 1. 
cells, analysis of  ~PCR V~ gene expression in LN T cells 
from naive mice or from mice that received SEB 7 d earlier 
was performed. Whereas V[38 + T cells represent roughly 
30% of  FSC l~ and FSC high CD4 + LN cells of  naive mice, 
the percentage of  T cells bearing this TCR V[3 segment is 
dramatically increased in the FSC l~ CD4 + subset from the 
SEB-treated mice (Fig. 1 C). Similar observations were 
made in the CD8 + subset (data not shown). This increase 
was specific to SEB-reactive V[38 + T cells since the pro- 
portion of  SEB-unresponsive V[36 + T cells was not in- 
creased in that same FSC l~ gate (Fig. 1 C). Interestingly, 
FSC l~ T cells express lower levels of  TCtk  than their 
FSC high counterparts (Fig. 1 C). This decrease in fluores- 
cence intensity is unlikely to be simply a reflection of  de- 
creased cell size since other cell surface markers uch as B220, 
CD4, or CD8 are expressed at similar levels in FSC l~ and 
FSC high populations (see below). 
SEB-reactive T Cells Undergo Normal Proliferation but Impaired 
Apoptosis n Fas-L-deficient gld Mice. To investigate whether 
SAg-induced FSC l~ cells are generated through the Fas 
pathway, we quantitated the accumulation of  V[38 + T cells 
in the FSC l~ gate from SEB-treated wild type (wt) mice or 
congenic Fas-L-deficient mice carrying the gld mutation. 
As seen in Fig. 2, there is a substantial increase in FSC l~ 
CD4 + V[38 + T cells in the wt mice 7 d after injection with 
SEB, compared to no selective increase in FSC l~ V[38 + T 
cells from gld mice. 
Next, we investigated whether the decreased accumula- 
tion of  FSC l~ cells in gld mice correlates with a lack of  
SEB-mediated eletion in these mice. Fig. 3 A shows a se- 
verely impaired eletion o fCD4 § V[38 + cells in gld mice as 
late as 14 d after administration of  the SAg. We have re- 
cently shown that proliferation is a prerequisite for SEB- 
induced T cell apoptosis (26). Thus, it was formally possi- 
ble that the lack of  SEB-mediated eletion in gld mice 
(Figs. 2 and 3 A) is the result of  an intrinsic inability of  their 
T cells to proliferate in response to SEB. We addressed this 
issue by quantitating the extent of  BrdU incorporation (as a 
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Figure 3. Normal proliferation but impaired apoptosis in SEB-injected 
gld mice. Wild type and gld mice that were fed BrdU continuously were 
injected with SEB. Their draining LN were dissociated, stained, and ana- 
lyzed by flow cytometry as described above. The percentage of (A) CD4 + 
VI38 + T cells; (B) cells that have incorporated BrdU; and (C) subdiploid 
cells, was assessed 4, 7, and 14 d after SEB injection. The data points on 
day 0 indicate the percentages obtained in control, untreated mice. 
measure of  proliferation) in BrdU-fed, SEB-injected wt 
and gld mice. We found that LN cells from gld mice incor- 
porated BrdU to the same extent in response to SEB as 
those derived from the wt mice (Fig. 3 B), and that this 
proliferation correlated with a substantial increase in V[38 + 
T cells (Fig. 3 A). However,  unlike in wt mice where a 
drastic drop in the percentage of  V[38 + T cells and of  
BrdU + cells occurred starting at day 7 after SEB, only a 
slight decrease in VI38 + cells could be observed in gld mice 
late in the response to SEB (day 14), correlating with a mi-  
nor and late drop in the percentage of  BrdU + cells (Fig. 3, 
A and B). The impaired deletion of  SEB-reactive cells in 
gld mice is due to reduced apoptosis of  these cells, which is 
in contrast o wt mice where a peak of  subdiploid (apop- 
totic) BrdU + cells can be detected at day 7 (Fig. 3 C). Col-  
433 Renno et al. 
ao 
0 
....................... i  oo 
0 
................ , b~ 
h 
..., ........ , ........ 
.................... d. .................... e . .  
. . . . . . . . . . . . . .  J.. 
FSC high 
FSC low 
Rabb i t  Ig ant i  - FAS  - L ant i  - FAS  ant i  - FAS  - L ant i  - FAS  
Figure 4. Fas and Fas-L expression on FSC high or FSC I~ T and B cells. BALB/c mice were injected with SEB, and cells from the draining LN were 
stained 7 d later with the following Abs: anti-CD4 and anti-CD8 (a, b, c,f g, and h) or anti-B220 (d, e, i, and j) in combination with control Ab (a and f), 
anti-Fas-L (b, g, d, and i), or anti-Fas (c, h, e, and j). (a-e) Cells that were gated on FSC ugh, while cells inf-j were gated on FSC 1~ CD4/8 indicates cells 
that were stained simultaneously with anti-CD4-PE and anti-CD8-PE at concentrations that allow discrimination between the two populations based on 
their different fluorescence intensities. The populations with a higher fluorescence intensity are CD8 § cells, and the populations with a lower intensity 
CD4 + cells. 
lectively, these data indicate that a functional Fas-L is re- 
quired for SAg- induced apoptosis to occur in vivo and that 
the generation of  most FSC l~ cells is dependent on this Fas- 
mediated apoptosis. 
Fas and Fas-L Are Upregulated on the SuoCace of FS~ ~ T 
and B Cells. Having established that the FSC ~~ gate pre- 
dominantly contains SAg-specific T cells undergoing Fas- 
dependent apoptosis in vivo, we studied the expression o f  
Fas and Fas-L in FSC high and FSC ~~ LN cells isolated from 
SEB-treated mice. Using novel  antibodies (19), we found 
that in FSC hlgh cells, Fas is expressed at low but detectable 
levels on CD4 + and CD8 + T cells and on B cells (Fig. 4, c 
and e) whereas Fas-L is expressed constitutively at low lev- 
els on B cells, but not on T cells (Fig. 4, b and d). By con-  
trast, Fas and Fas-L were substantially npregulated on both 
B and T cells in the FSC ]~ gate (Fig. 4, g-j) .  Fas and Fas-L 
staining was not due to FcR  binding since identical staining 
was obtained after preincubation with mAb to FcR  or with 
an excess o f  normal mouse Ig (not shown). Furthermore, 
staining with each o f  these Abs was specifically blocked 
with an excess o f  the relevant peptide (not shown). 
FSC ~~ T Cells That Express High Levels of Fas and Its 
D'gand A/so Express the B Cell Marker B220. Apoptotic T cells 
accumulat ing in the l iver express the B cell marker B220 
(6). Interestingly, we also find B220 expression on a pro-  
port ion o f  T cells in the FSC l~ gate o f  LN  from SEB- 
injected mice (Fig. 5 A). To  further characterize these cells, 
the expression o fCD4,  CD8,  B220, and either Fas or Fas-L 
was simultaneously examined on LN cells f rom SEB-  
treated mice. Cells were electronically gated on low for- 
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Figure 5. Fas and Fas-L expression by 
FSC I~ cells. LN cells from day 7 SEB mice 
were stained with anti-CD4, anti-CD8, and 
anti-B220, in combination with either con- 
trol Ab, anti-Fas, or anti-Fas-L. All events 
shown are gated on FSC I~ (A) Dot plot 
showing simultaneous B220 and CD4/8 
staining. The population in each quadrant is 
identified by a roman numeral and its per- 
centage is indicated. (B) Expression of Fas 
or Fas-L by different subpopulations identi- 
fied in (A). Shaded histograms, staining with 
anti-Fas or anti-Fas-L Abs; open histograms, 
staining with normal rabbit Ig. 
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ward scatter. Fig. 5 A shows that four distinct populations 
can be distinguished in the FSC l~ gate based on the ex- 
pression of CD4/8 and B220: (a) a CD4-8- ,  B220- popu- 
lation (quadrant I), presumably containing cells that have 
lost their membrane integrity since they cannot be stained 
with any of a panel of antibodies (Fig. 5, and not shown); 
(b) CD4/8 + (4 + or 8 +) B220- T cells (quadrant II); (c) 
CD4-8-  B220 + B cells (quadrant III); and (d) CD4/8 +, 
B220 + cells (quadrant IV). These latter cells were T cells by 
virtue of their expression of CD3, but not surface Ig, and 
were enriched in SEB-responsive VI38 + cells (not shown). 
The expression of Fas and Fas-L was then examined in 
each of these four populations. As expected, the CD4-8-  
B220- cells were negative for both molecules (Fig. 5 B,/). 
By contrast, B220- T cells showed a low staining with 
anti-Fas-L and an intermediate staining with anti-Fas (Fig. 
5 B, II). B cells exhibited abimodal (low and high) staining 
for Fas and Fas-L (Fig. 5 B, III). Interestingly, all B220 + T 
cells expressed high levels of both Fas and its ligand (Fig. 5 
B, IV). 
It is noteworthy that FSC l~ cells with the phenotypes 
described above are also found in LN from untreated mice. 
However, the percentage of B220 + LN T cells increases 
significantly in the FSC l~ gate upon treatment of mice 
with SEB (26% in untreated mice compared to 44% in day 
7 SEB-treated mice), and this increase is due to a selective 
accumulation ofSEB-reactive V]38 + T cells (data not shown). 
Discussion 
In this study, we have phenotypically characterized a 
population of apoptotic T cells generated during the course 
of the immune response to the bacterial SAg SEB in vivo. 
These cells, readily identifiable by their low forward scat- 
tering on a flow cytometer, a hallmark of apoptotic ells 
(13), express the CD4 or CD8 coreceptors, reduced levels 
of TCR, the B cell marker B220, and high levels of the apop- 
tosis-associated molecules, Fas and Fas-L. This novel phe- 
notype is presumably the product ofa Fas-dependent, apop- 
totic process ince the generation of these cells is impaired 
in Fas-L-deficient gld mice. 
In a recent report, the surface phenotype of cultured 
thymocytes undergoing apoptosis was studied using a new 
method (TUNEL) that detects DNA strand breaks (25). It 
was shown that all apoptotic (TUNEL +) cells were also 
FSC l~ and vice versa, further validating the use of FSC l~ 
as a marker of apoptosis. An advantage of FSC as an apop- 
tosis marker is that (unlike the fluorescent markers used to 
identify apoptotic ells) it does not occupy a fluorescence 
channel on the flow cytometer, thereby allowing the use of 
an additional marker in multiparameter cell phenotypic 
analysis of apoptotic ells. 
Previous reports have shown impaired T cell deletion in 
response to SAgs in Fas-defective Ipr mice (27, 28) or to 
antigenic peptide in TCR transgenic mice carrying the lpr 
mutation (29). We show here that this finding also applies 
to Fas-L-deficient gld mice immunized with SEB. We 
recently shown that SEB-mediated T cell apoptosis has to 
be preceded by proliferation (26). The fact that V[38 + T 
cells from gld mice respond to SEB by undergoing prolifer- 
ation in vivo rules out the possibility that the impaired 
apoptosis in these mice may be due to some intrinsic prolif- 
erative defect. Rather, we show direct evidence for re- 
duced apoptosis in the proliferating cell population. This 
finding is of relevance in light of the conflicting results re- 
garding the susceptibility of lpr T cells to apoptotic ell death 
(30-33). 
Since activation of T cells is a prerequisite for apoptosis 
in several experimental systems (26, 34-38), it is not unrea- 
sonable to expect that some markers found on apoptotic 
cells (such as B220, Fas, or Fas-L) would be expressed on 
their putative precursors, i.e., viable activated T cells. B220 
has been reported to be widely expressed on activated T
cells (6). We consistently find a small proportion (10%) of 
B220 + T cells among FSC high LN blast cells from SEB- 
primed mice. Furthermore, the majority of these FSC high 
B220 § T cell blasts upregulate their expression of Fas and 
Fas-L (not shown), suggesting that they may represent a
transitional population that will eventually become FSC I~ 
B220 + Fas high Fas-L high (apoptotic) cells. The accumulation 
ofFSChig hB220 + T cells in lpr orgld mice defective in Fas- 
dependent apoptosis (reviewed in reference 8) is likewise 
consistent with the hypothesis that B220 upregulation on T 
cells represents an intermediate stage in the process leading 
to Fas-mediated T cell death. 
Ifupregulation of Fas-L is required for induction ofapop- 
tosis (7, 39, 40), and since B220 + T cells are the predonfi- 
nant LN cell population that expresses high levels of this 
molecule, it follows that B220 + T cells are likely candidates 
to be involved in SAg-induced apoptosis. Since these same 
cells (in addition to some B cells) express high levels of Fas 
(also shown to be required for apoptosis [41]), three non- 
mutually exclusive mechanisms of Fas-dependent killing 
can be envisaged (42, 43): (a) B220 + T cells kill each other 
(fractricidal killing) (44); (b) B220 + T cells kill themselves 
in an autocrine fashion (suicidal killing) (45, 46); or (c) 
B220 § T cells are killed by B cells. This latter possibility is 
consistent with the fact that a proportion of FSC l~ B cells 
express high levels of Fas-L and that activated B cells from 
normal, but not gld mice, can kill Fas-bearing target cells 
under certain conditions (Hahne, M., T. Renno, M. 
Schroeter, M. Irmler, L. French, T. Bornand, H.R. Mac- 
Donald, and J. Tschopp, manuscript submitted for publica- 
tion). The mechanism of B cell activation by SEB in vivo is 
not known but may involve either cognate T-B interac- 
tion or direct activation via MHC class II cross-linking (re- 
viewed in reference 47). 
In summary, we have analyzed the surface phenotype of 
cells undergoing apoptosis in response to SEB in vivo. We 
show that apoptotic, SEB-reactive T cells express the B220 
marker and high levels of Fas and Fas-L. These data 
strongly implicate the Fas pathway in SAg-induced apopto- 
sis in vivo; however, the actual mechanism of Fas-depen- 
dent cell death remains to be elucidated. 
435 Renno et al. 
We thank Pierre Zaech for FACS | sorting and Hans Acha-Orbea for helpful discussion. 
T. Renno is supported by the Medical Research Council of Canada. M. Hahne is the recipient of a Human 
Frontiers of Science fellowship. J. Tschapp is supported by a grant from the Swiss National Science Founda- 
tion. 
Address correspondence to H. Robson MacDonald, Ludwig Institute for Cancer Research, Chenfin des 
Boveresses 155, 1066 Epalinges, Switzerland. 
Received for publication I4 April 1995 and in revised form 10 October 1995. 
References 
1. Webb, S., C. Morris, andJ. Sprent. 1990. Extrathymic toler- 
ance of mature T cells: clonal elimination as a consequence of 
immunity. Cell. 63:1249-1256. 
2. Kawabe, Y., and A. Ochi. 1991. Programmed cell death and 
extrathymic reduction of V[38 + CD4 + T cells in mice toler- 
ant to Staphylococcus a reus enterotoxin B. Nature (Lend.). 349: 
245-248. 
3. MacDonald, H.R., S. Baschieri, and R.K. Lees. 1991. Clonal 
expansion precedes anergy and death of V~38 + peripheral T 
cells responding to staphylococcal enterotoxin B in vivo. Eur. 
J. Immunol. 2l:1963-1966. 
4. Wahl, C., T. Miethke, K. Heeg, and H. Wagner. 1993. 
Clonal deletion as a direct consequence of an in vivo T cell 
response to bacterial superantigen. Eur. J. Immunol. 23:1197- 
1200. 
5. Kyburz, D., P. Aichele, D.E. Speiser, H. Hengartner, R.M. 
Zinkemagel, and H. Pircher. 1993. T cell immunity after a 
viral infection versus T cell tolerance induced by soluble viral 
peptides. Eur. J. Immunol. 23:1956-1962. 
6. Huang, L., G. Soldevila, M. Leeker, R. Flavell, and I.N. 
Crispe. 1995. The liver eliminates T cells undergoing anti- 
gen-triggered apoptosis n rive. Immunity. 1:741-749. 
7. Suda, T., T. Takahishi, P. Golstein, and S. Nagata. 1993. 
Molecular cloning and expression of the Fas ligand, a novel 
member of the tumor necrosis factor family. Cell 75:1169- 
1178. 
8. Nagata, S., and T. Suda. 1995. Fas and Fas ligand: lpr andgld 
mutations. Immunol. Today. 16:39-43, 
9. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing 
monoclonal ntibody (anti-Fas) to a cell surface antigen co- 
downregulated with the receptor of tumor necrosis factor. J. 
Exp. Med. 169:1747-1756. 
10. Arase, H., N. Arase, and T. Saito. 1995. Fas-mediated cyto- 
toxicity by freshly isolated natural killer cells. J. Exp. Med. 
181:1235-1238. 
11. Hanabuchi, S., M. Koyanagi, A. Kawasaki, N. Shinohara, A. 
Matsuzawa, Y. Nishimura, Y. Kobayashi, S. Yonehara, H. 
Yagita, and K. Okumura. 1994. Fas and its ligand in a general 
mechanism ofT-cell-mediated cytotoxicity. Prec. Natl. Acad. 
Sci. USA. 91:4930--4934. 
12. Alderson, M.R., T.W. Tough, T. Davis-Smith, S.Braddy, B. 
Falk, K.A. Schooley, R.G. Goodwin, C.A. Smith, F. Rams- 
dell, and D.H. Lynch. 1995. Fas ligand mediates activation- 
induced cell death in human T lymphocytes. J. Exp. Med. 
181:71-77. 
13. Darzynkiewicz, Z., S. Bruno, G. Del Bino, W. Gorczyca, 
M.A. Holtz, P. Lassota, and F. Traganos. 1992. Features of 
apoptotic ells measured by flow cytometry. Cytometry. 13: 
795-808. 
14. Lynch, D.H., M.L. Watson, M.R. Alderson, P.R. Baum, 
R.E. Miller, T. Tough, M. Gibson, T. Davis-Smith, C.A. 
Smith, K. Hunter, et al. 1994. The mouse Fas-ligand gene is 
mutated in gld mice and is part of a TNF family gene cluster. 
Immunity. 1:131-136. 
15. Takahashi, T., M. Tanaka, C.I. Brannan, N.A. Jenkins, N.G. 
Copeland, T. Suda, and S. Nagata. 1994. Generalized lym- 
phoproliferative disease in mice, caused by a point mutation 
in the Fas ligand. Cell. 76:969-976. 
16. Uematsu, Y., S. Ryser, Z. Dembic, P. Borgulya, P. Krimpen- 
fort, A. Berns, H. von Boehmer, and M. Steinmetz. 1988. In 
transgenic mice the introduced functional T cell receptor 
chain gene prevents expression of endogenous 13genes. Cell. 
52:831-841. 
17. Staerz, U.D., H. Rammensee, J. Benedetto, and M. Bevan. 
1985. Characterization f a murine monoclonal antibody 
specific for an allotypic determinant on T cell antigen recep- 
tor.J. Immunol. 134:3994-4000. 
18. Acha-Orbea, H., R.M. Zinkernagel, and H. Hengartner. 
1985. Cytotoxic T cell clone-specific monoclonal ntibodies 
used to select clonotypic antigen-specific cytotoxic T cells. 
Eur. J. Immunol. 15:31-36. 
19. Hahne, M., M.C. Peitsch, M. Irmler, M. Schroter, B. Lowin, 
M. Rousseau, C. Bron, T. Renno, L. French, and J. Tschopp. 
1995. Characterization f the non-functional Fas ligand ofgld 
mice. Int. Immunol. 7:1381-1386. 
20. Paramithiotis, E., K.A. Jacobsen, and M.J.H. Ratcliffe. 1995. 
Loss of surface immunoglobulin expression precedes B cell 
death by apoptosis n the bursa of Fabricius.J. Exp. Med. 181: 
105-113. 
21. Wyllie, A.H., J.F. Kerr, and A.R. Currie. 1980. Cell death: 
the significance ofapoptosis. Int. Rev. Cytol. 68:251-306. 
22. Swat, W., L. Ignatowicz, and P. Kisielow. 1991. Detection of 
apoptosis of immature CD4+8 + thymocytes by flow cytome- 
try, J. Immunol. Methods. 137:79-87. 
23. Lyons, A.B., K. Samuel, A. Sanderson, and A.H. Maddy. 
1992. Simultaneous analysis ofimmunophenotype andapop- 
tosis of murine thymocytes by single laser flow cytometry. 
Cytometry. 13:809-821. 
24. Schmid, I., C.H. Uittenbogaart, B. Keld, andJ. Giorgi. 1994. 
A rapid method for measuring apoptosis and dual-color im- 
munofluorescence by single laser flow cytometry. J. Immunol. 
Methods. 170:145-157. 
25. Kishimoto, H., C.D. Surh, andJ. Sprent. 1995. Upregnlation 
of surface markers on dying thymocytes. J. Exp. Med. 181: 
649-655. 
26. Renno, T., M. Hahne, and H.P,. MacDonald. 1995. Prolif- 
eration is a prerequisite for bacterial superantigen-induced T 
cell apoptosis in vivo.J. Exp. Med. 181:2283-2287. 
436 Surface Phenotype of Dying Superantigen-reactive T Cells 
27. Scott, D.E., W.J. Kisch, and A.D. Steinberg. 1993. Studies of 
T cell deletion and T cell anergy following in vivo adminis- 
tration of SEB to normal and lupus-prone mice. J. Immunol. 
150:664-672. 
28. Gonzalo, J.A., R. Tarazona, H.J. Schuurman, F. Huitdehaag, 
G. Wick, C. Martinez, and G. Kroemer. 1994. A single in- 
jection of Staphylococcus aureus enterotoxin B reduces autoim- 
munity in MLR/Ipr mice. Clin. Immunol. Immunopathol. 71: 
176-182. 
29. Singer, G.G., and A.K. Abbas. 1994. The Fas antigen is in- 
volved in peripheral but not thymic deletion of T lympho- 
cytes in T cell receptor transgenic mice. Immunity. 1:365- 
371. 
30. Russel, J.H., B. Rush, C. Weaver, and R. Wang. 1993. Ma- 
ture T cells ofautoimmune lpr/lpr mice have a defect in anti- 
gen-stimulated suicide. Proc. Natl. Acad. Sci. USA. 90:4409- 
4413. 
31. Reap, E.A., D. Leslie, M. Abrahams, R.A. Eisenberg, and 
P.L. Cohen. 1995. Apoptosis abnormalities of splenic lym- 
phocytes in autoimmune lpr and gld mice. J. lmmunol. 154: 
936-943. 
32. Gillette, F.I., and C.L. Sidman. 1994. A specific intercellular 
pathway of apoptotic ell death is defective in the mature pe- 
ripheral T cells ofautoimmune lpr andgld mice. Eur.J. Immu- 
nol. 24:1181-1185. 
33. Van Houten, N., and R.C. Bud& 1992. Accelerated pro- 
grammed cell death of MRL-lpr/lpr T lymphcytes. J. Immu- 
nol. 149:2513-2517. 
34. Boehme, S.A., and M.J. Lenardo. 1993. Propriocidal apopto- 
sis of mature T lymphocytes occurs at S phase of the cell cy- 
cle. Eur.J. Immunol. 23:1552-1560. 
35. Lenardo, M.J. 1991. Interleukin-2 programs mouse alpha 
beta T lymphocytes for apoptosis. Nature (Lond.). 353:858- 
861. 
36. Critchfield, J.M., M.K. Racke, P.J. Zuniga, B. Cannella, C.S. 
Raine, J. Goverman, and M.J. Lenardo. 1994. T cell deletion 
in high antigen dose therapy of autoimmune ncephalomy- 
elitis. Science (Wash. DC). 263:1139-1143. 
37. Ucker, D.S., J. Meyers, and P.S. Obermiller. 1992. Activa- 
tion-driven T cell death. II. Quantitative differences alone 
distinguish stimuli triggering nontransformed T cell prolifera- 
tion or death.J. Immunol. 149:1583-1592. 
38. Biasi, G., M. Panozzo, P. Pertile, S. Mezzalira, and A. 
Facchinetti. 1993. Mechanism underlying superantigen- 
induced clonal deletion of mature T lymphocytes. Int. Immu- 
nol. 6:983-989. 
39. Vignaux, F., and P. Golstein. 1994. Fas-based lymphocyte- 
mediated cytotoxicity against syngeneic activated lympho- 
cytes: a regulatory pathway. Eur. J. Immunol. 24:923-927. 
40. Ramsdell, F., M.S. Seaman, R.E. Miller, K.S. Picha, M.K. 
Kennedy, and D.H. Lynch. 1994. Differential ability of Thl 
and Th2 T cells to express Fas ligand and to undergo activa- 
tion-induced cell death. Int, Immunol. 6:1545-1553. 
41. Rouvier, E., M.-F. Luciani, and P. Golstein. 1993. Fas in- 
volvement in Ca2+-independent T cell-mediated cytotoxic- 
ity.J. Exp. Med. 177:195-200. 
42. Crispe, I.N. 1994. Fatal interactions: Fas-induced apoptosis of 
mature T cells. Immunity. 1:347-349. 
43. Nagata, S., and P. Golstein. 1995. The Fas death factor. Sci- 
ence (Wash. DC). 267:1449-1456. 
44. Suda, T., and S. Nagata. 1994. Purification and characteriza- 
tion of the Fas-ligand that induces apoptosis. J. Exp. Med. 
179:873-879. 
45. Dhein, J., H. Walczak, C. Baumler, K. Debatin, and P.H. 
Krammer. 1995. Autocrine T cell suicide mediated by APO- 
1/(Fas/CD95). Nature (Lond.). 373:438-441. 
46. Brunner, T., R.J. Mogli, D. LaFace, N. Yoo, A. Mahboubi, 
F. Echeverri, S.J. Martin, W.R. Force, D.H. Lynch, C.F. 
Ware, and D.R. Green. 1995. Cell-autonomous Fas (CD95)/ 
Fas-ligand interaction mediates activation-induced apoptosis 
in T-cell hybridomas. Nature (Lond.). 373:441-444. 
47. Mourad, W., R. E1-Daccak, T. Chatila, and R. Geha. 1993. 
Staphylococcal superantigens a inducers of signal transduc- 
tion in MHC class II-positive cells. Semin. Immunol. 5:47-55. 
437 Renno et al. 
